Strainprint™ – the leader in cannabis data collection and strain efficacy reporting – is excited to announce that 48North Cannabis (48North) has subscribed to Strainprint’s world-leading cannabis data & analytics platform to help guide its operational growth and product development.
Our Founder, Stephanie Karasick was recently profiled in HIGH Canada’s Women and Weed feature. Here she shares her personal medical cannabis journey, which was the genesis of the Strainprint App. Her full story can be found on page 58 of the December Edition.
National Post – Open Letter To ACMPR Medical Cannabis Patients Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post, share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.
Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.
Weedbox – Wanna Smoke More of the Right Weed? There’s An App for That! Recently, Strainprint was featured on Weedbox. Stephanie Karasick, Founder of Strainprint was interviewed about the app. Read her full interview and learn all about Strainprint below! View Article
On Friday, November 10th Strainprint Founder, Stephanie Karasick appeared on the 420 Radio Show. Get more information, or to listen to the full interview here!
On August 30th, 2017 Strainprint was featured on the Investing News Network. Our President, Dave Berg spoke to the Investing News Network about Strainprint and how we’re working to change the limitations of Medical Cannabis Research.